Will precision medicine improve population health?

JAMA - Journal of the American Medical Association

Volumn 316, Issue 13, 2016, Pages 1357-1358

  Khoury, Muin J ^a   Galea, Sandro ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFFECT SIZE; ETHNICITY; FUNDING; HEALTH; HEALTH CARE COST; HEALTH PROMOTION; HUMAN; NOTE; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; POPULATION; POPULATION HEALTH; PREDICTION; PRIORITY JOURNAL; PUBLIC HEALTH; RACE; DISEASES; FINANCIAL MANAGEMENT; GENETICS; HEALTH IMPACT ASSESSMENT; HEALTH STATUS INDICATOR; MOLECULARLY TARGETED THERAPY; PREVENTIVE MEDICINE; PROGRAM EVALUATION; RISK ASSESSMENT; THERAPY; TRENDS; UNITED STATES;

DISEASE; HEALTH IMPACT ASSESSMENT; HEALTH STATUS INDICATORS; HUMANS; MOLECULAR TARGETED THERAPY; PRECISION MEDICINE; PREVENTIVE MEDICINE; PROGRAM EVALUATION; PUBLIC HEALTH; RESEARCH SUPPORT AS TOPIC; RISK ASSESSMENT; THERAPEUTICS; UNITED STATES;

EID: 84993133873     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.12260     Document Type: Note

References (8)

1. Ashley EA. The precision medicine initiative: a new national effort. JAMA. 2015;313(21):2119-2120.
2. Joyner MJ, Paneth N. Seven questions for personalized medicine. JAMA. 2015;314(10):999-1000.
3. Hollands GJ, French DP, Griffin SJ, et al. The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ. 2016; 352:i1102.
4. Chetty R, Stepner M, Abraham S, et al. The association between income and life expectancy in the United States, 2001-2014. JAMA. 2016;315(16):1750-1766.
5. Maas P, Barrdahl M, Joshi AD, et al. Breast cancer risk from modifiable and nonmodifiable risk factors among white women in the United States [published online May 26, 2016]. JAMA Oncol. doi:10.1001/jamaoncol.2016.1025.
6. KhouryMJ, Evans JE. A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit. JAMA. 2015;313(21):2117-2118.
7. KhouryMJ, Iademarco MF, RileyWT. Precision public health for the era of precision medicine. Am J Prev Med. 2016;50(3):398-401.
8. Schulte PA, Whittaker C, Curran CP. Considerations for using genetic and epigenetic information in occupational health risk assessment and standard setting. J Occup Environ Hyg. 2015; 12(suppl 1):S69-S81.